| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
4,660 |
3,812 |
$175K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,074 |
2,447 |
$151K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
335 |
273 |
$9K |
| 81002 |
|
3,040 |
2,495 |
$8K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
94 |
82 |
$7K |
| 81025 |
|
1,262 |
1,021 |
$7K |
| 36415 |
Collection of venous blood by venipuncture |
2,542 |
2,089 |
$5K |
| 92587 |
|
101 |
94 |
$5K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
45 |
43 |
$3K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
116 |
99 |
$2K |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
18 |
16 |
$1K |
| 96127 |
|
282 |
248 |
$1K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
101 |
86 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
45 |
43 |
$585.99 |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
14 |
13 |
$519.69 |
| 36410 |
|
33 |
29 |
$412.70 |
| 81003 |
|
165 |
132 |
$285.94 |
| 3008F |
|
175 |
136 |
$240.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
89 |
78 |
$161.48 |
| 90688 |
|
15 |
12 |
$136.29 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
77 |
65 |
$76.36 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
15 |
14 |
$52.66 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
380 |
288 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
289 |
255 |
$0.00 |
| G8431 |
Screening for depression is documented as being positive and a follow-up plan is documented |
91 |
67 |
$0.00 |
| G8783 |
Normal blood pressure reading documented, follow-up not required |
101 |
91 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
186 |
136 |
$0.00 |
| T1013 |
Sign language or oral interpretive services, per 15 minutes |
15 |
14 |
$0.00 |
| G8942 |
Functional outcome assessment using a standardized tool is documented within the previous 30 days and a care plan, based on identified deficiencies is documented within two days of the functional outcome assessment |
17 |
12 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
15 |
14 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
333 |
277 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
360 |
282 |
$0.00 |
| G8420 |
Bmi is documented within normal parameters and no follow-up plan is required |
57 |
47 |
$0.00 |
| G8950 |
Elevated or hypertensive blood pressure reading documented, and the indicated follow-up is documented |
216 |
157 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
15 |
14 |
$0.00 |
| 3017F |
|
31 |
25 |
$0.00 |
| G8542 |
Functional outcome assessment using a standardized tool is documented; no functional deficiencies identified, care plan not required |
37 |
30 |
$0.00 |